BioFabUSA News
Union Leader: Millyard lab will be used to manufacture human tissue for clinical trials
It’s been nearly five years since Dean Kamen announced the launch of BioFabUSA, a program of the Advanced Regenerative Manufacturing Institute to jump-start the large-scale production of synthetic human tissue. Under the direction of Chief Technology Officer Tom Bollenbach, BioFabUSA has created a “tissue foundry” as a working prototype to manufacture cells, which increases the rate needed to produce them for early clinical trials.
For media inquiries:
Director of Communications
Brett Brune
bbrune@www.armiusa.org
